Garner Asset Management Corp Merck & Co., Inc. Transaction History

Garner Asset Management Corp

  • $244 Million
  • Q3 2025

A detailed history of Garner Asset Management Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Garner Asset Management Corp holds 5,929 shares of MRK stock, worth $550,566. This represents 0.2% of its overall portfolio holdings.

Number of Shares
5,929
Previous 5,479 8.21%
Holding current value
$550,566
Previous $433,000 14.78%
% of portfolio
0.2%
Previous 0.2%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
BUY
$77.6 - $87.37 $34,920 - $39,316
450 Added 8.21%
5,929 $497,000
Q2 2025

Aug 12, 2025
SELL
$73.47 - $87.12 $81,551 - $96,703
-1,110 Reduced 16.85%
5,479 $433,000
Q1 2025

May 05, 2025
SELL
$83.01 - $101.02 $89,982 - $109,505
-1,084 Reduced 14.13%
6,589 $591,000
Q4 2024

Feb 13, 2025
SELL
$96.31 - $114.76 $6,549 - $7,803
-68 Reduced 0.88%
7,673 $763,000
Q3 2024

Nov 12, 2024
SELL
$111.15 - $128.97 $16,894 - $19,603
-152 Reduced 1.93%
7,741 $879,000
Q2 2024

Aug 12, 2024
BUY
$123.8 - $132.96 $68,956 - $74,058
557 Added 7.59%
7,893 $977,000
Q1 2024

May 16, 2024
BUY
$113.24 - $131.95 $37,029 - $43,147
327 Added 4.67%
7,336 $968,000
Q4 2023

Feb 14, 2024
SELL
$100.18 - $109.02 $35,664 - $38,811
-356 Reduced 4.83%
7,009 $764,000
Q3 2023

Nov 14, 2023
SELL
$102.95 - $114.33 $52,710 - $58,536
-512 Reduced 6.5%
7,365 $834,000
Q2 2023

Aug 14, 2023
SELL
$108.61 - $118.38 $163,240 - $177,925
-1,503 Reduced 16.02%
7,877 $909,000
Q1 2023

May 15, 2023
SELL
$102.94 - $114.86 $30,779 - $34,343
-299 Reduced 3.09%
9,380 $998,000
Q4 2022

Feb 14, 2023
SELL
$87.44 - $112.11 $961 - $1,233
-11 Reduced 0.11%
9,679 $1.07 Million
Q3 2022

Nov 14, 2022
SELL
$84.53 - $94.96 $138,375 - $155,449
-1,637 Reduced 14.45%
9,690 $835,000
Q2 2022

Jul 29, 2022
BUY
$83.49 - $94.64 $137,341 - $155,682
1,645 Added 16.99%
11,327 $1.03 Million
Q1 2022

Apr 29, 2022
BUY
$73.51 - $82.4 $367 - $412
5 Added 0.05%
9,682 $794,000
Q4 2021

Jan 31, 2022
BUY
$72.28 - $90.54 $361 - $452
5 Added 0.05%
9,677 $742,000
Q3 2021

Oct 29, 2021
BUY
$71.68 - $78.83 $2,938 - $3,232
41 Added 0.43%
9,672 $727,000
Q2 2021

Aug 03, 2021
SELL
$70.31 - $77.77 $11,952 - $13,220
-170 Reduced 1.73%
9,631 $749,000
Q1 2021

Apr 30, 2021
SELL
$68.86 - $81.11 $41,384 - $48,747
-601 Reduced 5.78%
9,801 $756,000
Q4 2020

Jan 29, 2021
BUY
$71.77 - $79.65 $3,875 - $4,301
54 Added 0.52%
10,402 $851,000
Q3 2020

Oct 30, 2020
SELL
$73.18 - $82.95 $5,195 - $5,889
-71 Reduced 0.68%
10,348 $858,000
Q2 2020

Jul 27, 2020
BUY
$70.42 - $80.13 $50,772 - $57,773
721 Added 7.43%
10,419 $806,000
Q1 2020

Apr 27, 2020
BUY
$63.36 - $87.82 $51,701 - $71,661
816 Added 9.19%
9,698 $746,000
Q4 2019

Jan 17, 2020
SELL
$77.58 - $87.54 $3,801 - $4,289
-49 Reduced 0.55%
8,882 $808,000
Q3 2019

Oct 29, 2019
SELL
$76.08 - $82.93 $47,397 - $51,665
-623 Reduced 6.52%
8,931 $752,000
Q2 2019

Jul 19, 2019
SELL
$69.84 - $81.59 $13,898 - $16,236
-199 Reduced 2.04%
9,554 $801,000
Q1 2019

Apr 23, 2019
BUY
$69.58 - $79.36 $19,551 - $22,300
281 Added 2.97%
9,753 $811,000
Q4 2018

Jan 29, 2019
SELL
$65.24 - $75.71 $4,175 - $4,845
-64 Reduced 0.67%
9,472 $724,000
Q3 2018

Oct 29, 2018
BUY
$57.69 - $67.84 $115 - $135
2 Added 0.02%
9,536 $676,000
Q2 2018

Jul 19, 2018
BUY
$50.83 - $59.72 $15,299 - $17,975
301 Added 3.26%
9,534 $579,000
Q1 2018

Apr 27, 2018
BUY
$50.96 - $59.23 $43,672 - $50,760
857 Added 10.23%
9,233 $0
Q4 2017

Jan 30, 2018
BUY
$51.62 - $61.64 $5,213 - $6,225
101 Added 1.22%
8,376 $471,000
Q3 2017

Oct 27, 2017
BUY
$58.67 - $63.13 $8,800 - $9,469
150 Added 1.85%
8,275 $530,000
Q2 2017

Aug 14, 2017
BUY
N/A
8,125
8,125 $521,000

Others Institutions Holding MRK

# of Institutions
3,881
Shares Held
1.9B
Call Options Held
30.1M
Put Options Held
27.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Garner Asset Management Corp Portfolio

Follow Garner Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garner Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Garner Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email